In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3315-3316

  Shoen, Carolyn M ^a   Choromanska, Olga ^a   Reynolds, Robert C ^b   Piper, James R ^b   Johnson, Cheryl A ^b   Cynamon, Michael H ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINO 6 [[(2,5 DIMETHOXYPHENYL)AMINO]METHYL] 5 METHYLPYRIDO[2,3 D]PYRIMIDINE; 2,4 DIAMINO 6 [[(3,5 DIMETHOXYPHENYL)AMINO]METHYL] 5 METHYLPYRIDO[2,3 D]PYRIMIDINE; 2,4 DIAMINO 6 [[[2 METHOXY 5 (TRIFLUOROMETHYL)PHENYL]AMINO]METHYL] 5 METHYLPYRIDO[2,3 D]PYRIMIDINE; 4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; DAPSONE; DIHYDROFOLATE REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL;

EID: 0031789447     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3315     Document Type: Article

References (9)

1. Gangadharam, P. R. J. 1995. Beige mouse model for Mycobacterium avium complex disease. Antimicrob. Agents Chemother. 39:1647-1654.
2. Hughes, W. T., S. Feldman, and S. K. Sanyal. 1975. Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Can. Med. Assoc. J. 112:47S-50S.
3. Lau, W. K., and L. S. Young. 1976. Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N. Engl. J. Med. 295:716-718.
4. Leoung, G. S., J. Mills, P. C. Hopewell, W. Hughes, and C. Wofsy. 1986. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome. Ann. Intern. Med. 105:45-48.
5. Leport, C., F. Raffi, S. Matheron, C. Katlama, B. Regnier, A. G. Saimot, C. Marche, C. Vedrenne, and J. L. Vilde. 1988. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am. J. Med. 84:94-100.
6. Piper, J. R., C. A. Johnson, C. A. Krauth, R. L. Carter, C. A. Hosmer, S. F. Queener, S. E. Borotz, and E. R. Pfefferkorn. 1996. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. J. Med. Chem. 39:1271-1280.
7. Seydel, J. K. 1993. In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and Mycobacterium. J. Chemother. 5:422-429.
8. Shah, L. M., S. C. C. Meyer, and M. H. Cynamon. 1996. Enhanced in vitro activity of pyrimethamine in combination with dapsone against Mycobacterium avium complex. Antimicrob. Agents Chemother. 40:2426-2427.
9. Shah, L. M., M. S. DeStefano, and M. H. Cynamon. 1996. Enhanced in vitro activity of WR99210 in combination with dapsone against Mycobacterium avium complex. Antimicrob. Agents Chemother. 40:2644-2645.